Infectivity of blood products from donors with occult hepatitis B virus infection.
about
Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus InfectionMolecular Mechanisms to Control Post-Transplantation Hepatitis B RecurrenceSubgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestineOccult hepatitis B viral infection among blood donors in South-Eastern NigeriaHepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.Occult hepatitis B virus infection and blood transfusionHepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases.Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq.Virus and Host Testing to Manage Chronic Hepatitis B.Medical virology of hepatitis B: how it began and where we are nowOccult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy.A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia.Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus.Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India.Hepatitis B transmission by cell and tissue allografts: how safe is safe enough?Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Occult hepatitis B virus infection in Egypt.Screening and diagnosis of HBV in low-income and middle-income countries.Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion-transmitted infection in Argentina: high rate of recent infections.Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.Refining the risk estimate for transfusion-transmission of occult hepatitis B virus.Use of supplemental anti-HBc testing of donors showing non-discriminating reactive results in multiplex nucleic acid testing.A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios.Rare transmission of hepatitis B virus by Dutch donors with occult infection.Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection.Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors.Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc TestingThe yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme.Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin.What is the meaning of a nonresolved viral nucleic acid test-reactive minipool?Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening.Stochastic model for estimating the risk of transfusion-transmitted hepatitis B in Vietnam.Occult hepatitis B infections among blood donors in Lao PDR.
P2860
Q26775638-942346AB-52DC-49D4-9399-0BDF3B3A2A66Q26799246-ABFCDF09-2CF6-4814-A0C0-1F83E9FBACE8Q28542694-952CA62E-FEEC-4E19-871C-79E6A5E61D94Q34129673-CAEDFFF9-500A-4354-A58A-0D68CFD5732FQ35164580-F1D192A7-069B-4436-862D-E8078EE9C467Q35237335-27B1D7CC-4F93-437B-95E6-C0FBE3339645Q35274812-DE0E5A34-B1C3-4850-B774-76B32F937930Q36662183-DD1867FC-04FE-44DA-802D-334AE26EFA13Q36958940-31AC6319-82F4-4DE2-A7D6-D266340E2ACBQ37059714-4C4874ED-6187-4F2D-8EBD-59D771B84DA5Q37305696-3CF5B939-6BFE-4EEA-8465-15BDDE5C77AAQ37305718-8748457F-BD1D-43C4-B5C6-BB11246446E9Q37418340-A658F4E8-497F-4F57-9FD6-F9FC5E073B48Q37618604-B8458452-EB0E-4424-9A50-33BA46CF044EQ38194183-117B3BB5-C58B-45DD-A9E8-ABB45820B02FQ38223372-82F2D336-EE38-4803-BFF7-F4E4CEEEB0FBQ38293584-EF26A062-0C41-4784-9688-F6DE7954043BQ38536404-67BEA24B-4339-4BFE-82C6-F27F54A75934Q38542377-F6A65284-3BA3-4C56-9A0D-E83D175673D8Q38953790-93EF63F5-AB88-4C98-8B9E-CF005685BB79Q39131395-3EFB013C-6288-4BFD-8049-6DE56963E856Q39347172-9F453175-34E9-4397-88A0-AD88A9284991Q39450759-C38B00E0-9E02-46F4-B94A-3BBD4A02D350Q40048372-F4C3BC19-CF84-486C-8AE9-8F5E879212F2Q40314561-EA6298BF-BC94-45E5-A032-F37EAF3A6ECBQ40331727-381817B6-92C6-496F-A735-936E16F7DB60Q40613598-7333AA3C-70D5-4B82-9649-D9B6A36E408CQ40623803-D36A595D-5D3E-4C4D-B48D-DB446E671002Q40818421-6BEDC9EE-C4AB-45D7-8298-AC19442E3244Q41107028-0F2FA6D4-4994-4D45-8193-0086B7A431EDQ41111337-80676FD3-BDE1-421C-9C6D-EDCA2E465164Q41606333-B0D35B18-7DDE-4AEB-8E56-046547915B2DQ41680549-B62C39E9-2DCC-4DBD-8796-DA480F343AA1Q41734031-019F0E7C-13AD-417B-9ED0-FC08EA269E8CQ42173073-ECC38B5E-05C1-451D-A779-133ED88CA674Q42199830-B2EFB618-20CA-4E9D-BB3B-526841AF15AFQ42230165-C9881FC0-9F44-46B2-A05F-20DE5979412FQ42257442-06836B9B-F6D3-45CC-86DC-BC0D7BA3F4F1Q42258103-C50417BF-1F90-4299-A47D-F8258E985F8CQ42277833-F69BEC58-6124-4FBB-B5C9-55F4C5A411A9
P2860
Infectivity of blood products from donors with occult hepatitis B virus infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Infectivity of blood products from donors with occult hepatitis B virus infection.
@en
Infectivity of blood products from donors with occult hepatitis B virus infection.
@nl
type
label
Infectivity of blood products from donors with occult hepatitis B virus infection.
@en
Infectivity of blood products from donors with occult hepatitis B virus infection.
@nl
prefLabel
Infectivity of blood products from donors with occult hepatitis B virus infection.
@en
Infectivity of blood products from donors with occult hepatitis B virus infection.
@nl
P2093
P2860
P356
P1433
P1476
Infectivity of blood products from donors with occult hepatitis B virus infection.
@en
P2093
Christian Erikstrup
Daniel Candotti
Ivanka Mihaljevic
Jean-Pierre Allain
Jose Maria Garcia
Knut Gubbe
Lene Holm-Harritshøj
Lorenz Wernish
Lydia Bianco
Maria Isabel Gonzalez-Fraile
P2860
P304
P356
10.1111/TRF.12096
P577
2013-01-30T00:00:00Z